Product
ARG1-18,19,20
1 clinical trial
8 indications
Indication
Lung CancerIndication
Bladder CancerIndication
MelanomaIndication
Ovarian CancerIndication
Colorectal CancerIndication
Breast CancerIndication
Metastatic CancerClinical trial
Arginase-1 Peptide Vaccine in Patients With Metastatic Solid TumorsStatus: Completed, Estimated PCD: 2022-01-19